10/9/2020China Reduces VAT on A New Batch of Anticancer Drugs

10/9/2020Recent Executive Moves

10/9/2020NMPA Issues the Guide to Pharmaceutical Contract Manufacture Quality A...

10/8/2020Boehringer Ingelheim Pledges Continued Direct Investments in China

10/8/2020Lilly and Innovent Close the Expanded Global Collaboration on TYVYT (S...

10/7/2020Harbour BioMed Announces Two NMPA IND Clearances for Phase 1 & Combo ...

10/4/2020Q&A with Pfizer CentreOne on Contract Manufacturing for China

9/30/2020NMPA Issues the Rules for Medical Representative Filing Management

9/30/2020IQVIA: Chinese Hospital Drug Market Down 15.3% in Q2/2020

9/30/2020Financial-related Company News in Brief

9/29/2020Beijing Court Rules Over Shareholder In-fighting of Sinovac

9/29/2020Apollomics Granted Chinese IND Approval for APL-106 in Acute Myeloid L...

9/29/2020TYVYT and BYVASDA Combo Study Meets Its Primary Endpoints

9/29/2020JD Health Files for Hong Kong IPO

9/28/2020China Resources Pharma Agrees to Acquire Plasma Company Boya Biopharma

9/28/2020NMPA Issues the Registration Classification and Dossier Requirements o...

9/27/2020CPA Initiates Platform to Prepare for Medical Representative Registrat...

9/25/2020BioDuro and Sundia Tie Up to Become Industry Leading CRDMO

9/25/2020Snapshot of R&D Spending of Listed Chinese Pharma Companies in H1/2020

9/25/2020Review of Chinese Pharma Licensing Trends 2015-2019

9/25/2020IQVIA: China Represents 11% of Global Vaccine Market

9/25/2020Performance Review of A Share-Listed Chinese MedPharm Companies in the...

9/24/2020AZ Ties Up with Samsung Biologics to Boost Asian Manufacturing Capacit...

9/24/2020AstraZeneca to Market OM Pharma's Lyophilized Bacterial Lysates Capsul...

9/23/2020Fitch: China's Medical Insurance Scheme Reform Neutral for Retail Phar...

9/22/2020GNC Sale to Harbin Pharma Blessed by Court

9/22/2020I-Mab Cleared in China for P1 Trial of Lemzoparlimab in Relapsed or Re...

9/21/2020CDE Solicits Comments on the Technical Requirements for Pharmaceutical...

9/18/2020WiCON Publishes the China Pharmaceutical Guide 2020 (15th Edition)

9/18/2020MorphoSys and I-Mab Cleared by FDA for IND of Anticancer MOR210/TJ21...

Page:116/367 Total number of articles:10996: [First][<<] [114] [115] [116] [117] [118] [>>] [End]